Sam Chun Dang Pharm. Co., Ltd

Total Valuation

Sam Chun Dang Pharm. Co., Ltd carries a market capitalization of 4.79T, placing it among publicly traded companies globally. Its enterprise value stands at 19.35T, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Sam Chun Dang Pharm. Co., Ltd currently has 23.26M shares outstanding.

Valuation Ratios

Sam Chun Dang Pharm. Co., Ltd trades at a trailing price-to-earnings ratio of 1,887.73. The price-to-sales ratio is 78.50, and the price-to-book ratio stands at 172.53.

Enterprise Valuation

On an enterprise value basis, Sam Chun Dang Pharm. Co., Ltd trades at an EV/EBITDA multiple of 1,462.84 and an EV/FCF ratio of 277.17. The EV/Sales ratio of 78.64 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 1,462.84 provides insight into valuation relative to core operating earnings.

Financial Position

Sam Chun Dang Pharm. Co., Ltd maintains a current ratio of 2.18, meaning it holds 2.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 12.35, indicating elevated leverage, while an interest coverage ratio of 14.39 demonstrates strong ability to service its debt obligations.

Financial Efficiency

Sam Chun Dang Pharm. Co., Ltd posts a return on equity of 9.52 and a return on invested capital of 2.83.

Taxes

Over the trailing twelve months, Sam Chun Dang Pharm. Co., Ltd has paid 1.74B in income taxes, reflecting an effective tax rate of 8.96.

Stock Price Statistics

Sam Chun Dang Pharm. Co., Ltd's stock has gained approximately 32.61997% over the past 52 weeks. The 50-day moving average sits at 326,230.00, while the 200-day moving average is 381,927.00.

Income Statement

Over the trailing twelve months, Sam Chun Dang Pharm. Co., Ltd generated 246.05B in revenue and converted that into 10.23B in net income, yielding earnings per share of 757.98. EBITDA reached 13.23B, while operating income came in at 13.23B.

Balance Sheet

Sam Chun Dang Pharm. Co., Ltd holds 110.37B in cash and equivalents against 48.72B in total debt, resulting in a net debt position of -39.50B. Total book value stands at 111.95B, with working capital of 130.31B providing operational flexibility.

Cash Flow

Sam Chun Dang Pharm. Co., Ltd produced -1.13B in operating cash flow over the past twelve months. After subtracting -70.11B in capital expenditures, free cash flow totaled -71.24B - equivalent to -3,057.37 per share.

Margins

Sam Chun Dang Pharm. Co., Ltd operates with a gross margin of 47.33, reflecting its pricing power and cost economics. The operating margin of 5.38 and net profit margin of 4.16 provide insight into operational efficiency.

Dividends & Yields

Scores

Sam Chun Dang Pharm. Co., Ltd posts an Altman Z-Score of 66.21, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.